Literature DB >> 18796522

Association of the Kir6.2 E23K variant with reduced acute insulin response in African-Americans.

Nicholette D Palmer1, Carl D Langefeld, Michael Bryer-Ash, Jerome I Rotter, Kent D Taylor, Donald W Bowden.   

Abstract

CONTEXT: ATP-sensitive potassium channels are composed of pore-forming (Kir6.x) and regulatory sulfonylurea receptor (SURx) subunits and have been implicated in the maintenance of glucose homeostasis. Kir6.2 and SUR1 are expressed in a broad range of tissues, and no contemporary studies have addressed the physiological impact of variants in Hispanic-Americans and African-Americans carefully phenotyped for components of glucose homeostasis.
OBJECTIVE: The objective of this study was to evaluate two nonsynonymous variants in Kir6.2 (E23K) and SUR1 (A1369S) and determine their role in vivo. DESIGN AND
SETTING: The Insulin Resistance Atherosclerosis Family Study (IRAS-FS) is a community-based study of Hispanic-Americans (San Antonio, TX, and San Luis Valley, CO) and African-Americans (Los Angeles, CA). PARTICIPANTS: A total of 1,040 Hispanic-Americans and 500 African-American individuals formed the basis of this study. MAIN OUTCOME MEASURE(S): The primary glucose homeostasis phenotypes of interest in this study were derived from the frequently sampled iv glucose tolerance test and included insulin sensitivity (S(I)), acute insulin response, and disposition index.
RESULTS: In African-Americans, both variants were associated with a significant reduction in insulin secretion in glucose-tolerant carriers of the minor alleles (additive P = 0.00053). S(I), a measure of insulin sensitivity, was not associated. In Hispanic-Americans, there was no association with measures of glucose homeostasis.
CONCLUSIONS: We conclude that variation marked by the Kir6.2 E23K and SUR1 A1369S mutations is associated with alterations in glucose-stimulated insulin secretion but not with other measures of glucose homeostasis in an African-American population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18796522      PMCID: PMC2626454          DOI: 10.1210/jc.2008-0543

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  29 in total

1.  K(IR)6.2 polymorphism predisposes to type 2 diabetes by inducing overactivity of pancreatic beta-cell ATP-sensitive K(+) channels.

Authors:  Christina Schwanstecher; Ulrike Meyer; Mathias Schwanstecher
Journal:  Diabetes       Date:  2002-03       Impact factor: 9.461

2.  Candidate gene association analysis for a quantitative trait, using parent-offspring trios.

Authors:  W James Gauderman
Journal:  Genet Epidemiol       Date:  2003-12       Impact factor: 2.135

3.  Quantitative traits associated with the Type 2 diabetes susceptibility allele in Kir6.2.

Authors:  M N Weedon; A L Gloyn; T M Frayling; A T Hattersley; G Davey Smith; Y Ben-Shlomo
Journal:  Diabetologia       Date:  2003-06-18       Impact factor: 10.122

4.  Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods.

Authors:  Leora Henkin; Richard N Bergman; Donald W Bowden; Darrell L Ellsworth; Steven M Haffner; Carl D Langefeld; Braxton D Mitchell; Jill M Norris; Marian Rewers; Mohammed F Saad; Elizabeth Stamm; Lynne E Wagenknecht; Stephen S Rich
Journal:  Ann Epidemiol       Date:  2003-04       Impact factor: 3.797

Review 5.  Accurate assessment of beta-cell function: the hyperbolic correction.

Authors:  Richard N Bergman; Marilyn Ader; Katrin Huecking; Gregg Van Citters
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

Review 6.  The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes.

Authors:  R N Bergman; D T Finegood; S E Kahn
Journal:  Eur J Clin Invest       Date:  2002-06       Impact factor: 4.686

7.  Minimal model-based insulin sensitivity has greater heritability and a different genetic basis than homeostasis model assessment or fasting insulin.

Authors:  Richard N Bergman; Daniel J Zaccaro; Richard M Watanabe; Steven M Haffner; Mohammed F Saad; Jill M Norris; Lynne E Wagenknecht; James E Hokanson; Jerome I Rotter; Steven S Rich
Journal:  Diabetes       Date:  2003-08       Impact factor: 9.461

8.  The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes.

Authors:  Eva-Maria D Nielsen; Lars Hansen; Bendix Carstensen; Søren M Echwald; Thomas Drivsholm; Charlotte Glümer; Birger Thorsteinsson; Knut Borch-Johnsen; Torben Hansen; Oluf Pedersen
Journal:  Diabetes       Date:  2003-02       Impact factor: 9.461

9.  Variations in insulin secretion in carriers of the E23K variant in the KIR6.2 subunit of the ATP-sensitive K(+) channel in the beta-cell.

Authors:  Leen M 't Hart; Timon W van Haeften; Jacqueline M Dekker; Martine Bot; Robert J Heine; J Antonie Maassen
Journal:  Diabetes       Date:  2002-10       Impact factor: 9.461

Review 10.  Neonatal and very-early-onset diabetes mellitus.

Authors:  Michel Polak; Julian Shield
Journal:  Semin Neonatol       Date:  2004-02
View more
  5 in total

Review 1.  The molecular genetics of sulfonylurea receptors in the pathogenesis and treatment of insulin secretory disorders and type 2 diabetes.

Authors:  Veronica Lang; Nermeen Youssef; Peter E Light
Journal:  Curr Diab Rep       Date:  2011-12       Impact factor: 4.810

2.  Genetic variations in magnesium-related ion channels may affect diabetes risk among African American and Hispanic American women.

Authors:  Kei Hang K Chan; Sara A Chacko; Yiqing Song; Michele Cho; Charles B Eaton; Wen-Chih H Wu; Simin Liu
Journal:  J Nutr       Date:  2015-01-07       Impact factor: 4.798

3.  The ATP-sensitive K(+) channel ABCC8 S1369A type 2 diabetes risk variant increases MgATPase activity.

Authors:  Mohammad Fatehi; Mobeen Raja; Christian Carter; Daniel Soliman; Andrew Holt; Peter E Light
Journal:  Diabetes       Date:  2012-01       Impact factor: 9.461

4.  Kir6.2 variant E23K increases ATP-sensitive K+ channel activity and is associated with impaired insulin release and enhanced insulin sensitivity in adults with normal glucose tolerance.

Authors:  Dennis T Villareal; Joseph C Koster; Heather Robertson; Alejandro Akrouh; Kazuaki Miyake; Graeme I Bell; Bruce W Patterson; Colin G Nichols; Kenneth S Polonsky
Journal:  Diabetes       Date:  2009-06-02       Impact factor: 9.461

5.  TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action.

Authors:  Dennis T Villareal; Heather Robertson; Graeme I Bell; Bruce W Patterson; Hung Tran; Burton Wice; Kenneth S Polonsky
Journal:  Diabetes       Date:  2009-11-23       Impact factor: 9.461

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.